Cancer Genomics Education Program

The Division of Clinical Cancer Genomics at City of Hope offers educational courses and self-teaching tools for professionals in the fields of cancer and cancer genetics. This Cancer Genomics Education Program is supported in part by funding from the NCI (IRC4CA153828-01 andIR25CA112486).

Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genomics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.

Cancer Genomics Career Development Program

City of Hope offers an innovative Cancer Genomics Career Development Program which provides interdisciplinary training focused on cancer genetics and cancer prevention control research. The traineeship is open to three applicants per year.

Intensive Course in Cancer Risk Assessment

City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multimodal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.

Clinical Cancer Genomics Community of Practice

City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.